SCHEMBL24776019

SCHEMBL24776019

CC(C)c1c(-c2cccc3sc4ccccc4c23)cccc1C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.39
BRDT Q58F21 1/20 0.34
KIF11 P52732 1/20 0.32
DUSP3 P51452 2/20 0.32
PTPN7 P35236 1/20 0.32
PTPN12 Q05209 1/20 0.32
PTPN22 Q9Y2R2 1/20 0.32
PARP14 Q460N5 1/20 0.32
MAPT P10636 4/20 0.31
HPGD P15428 2/20 0.31
RAB9A P51151 2/20 0.31
ALDH1A1 P00352 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
ALOX5 P09917 1/20 0.31
MEN1 O00255 1/20 0.31
POLB P06746 1/20 0.31
BLM P54132 1/20 0.31
PTPN5 P54829 1/20 0.31
KMT2A Q03164 1/20 0.31
PTPN11 Q06124 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21971994 0.85 GPR3 (0.47) GPR3BRDTKIF11DUSP3PTPN7
Bromide SCHEMBL28718552 0.82 GPR3 (0.44) GPR3BRDTKIF11DUSP3PTPN7
SCHEMBL26073643 0.81 GPR3 (0.42) GPR3BRDTKIF11DUSP3PTPN7
SCHEMBL21971533 0.81 GPR3 (0.42) GPR3BRDTKIF11DUSP3PTPN7
SCHEMBL26270551 0.81 GPR3 (0.42) GPR3BRDTKIF11DUSP3PTPN7
SCHEMBL26166157 0.81 BRDT (0.36) GPR3BRDTKIF11RAB9AALDH1A1
SCHEMBL24433619 0.80 BRDT (0.38) GPR3BRDTDUSP3MAPTHPGD
SCHEMBL2388003 0.80 GPR3 (0.56) GPR3KIF11DUSP3PTPN7PTPN12
SCHEMBL25700671 0.78 GPR3 (0.35) GPR3BRDTDUSP3PTPN7PTPN12
SCHEMBL21972208 0.77 GPR3 (0.43) GPR3BRDTDUSP3PTPN7PTPN12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220396596-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220396596-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, DRD3 GPR3 14/4885BRDT 792/4885KIF11 4443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.